Phage-conjugated magnetic bead technology for Salmonella detection

Technology
Conceptual
University

Innovative phage-conjugated magnetic bead technology enhances Salmonella detection by reducing false positives and improving sensitivity. This method, combined with dd-PCR, offers rapid detection in food and environmental samples, completing the process within 2 hours.

Overview

The proposed solution introduces an innovative phage-conjugated magnetic bead (pMBs) technology designed to improve the detection of Salmonella in food and environmental samples. Unlike traditional methods that rely on antibody-coated paramagnetic particles, this new approach utilizes bacteriophages, which are highly specific to target pathogens and can differentiate between viable and non-viable bacteria, thereby minimizing false positive results. This technology, combined with droplet digital PCR (dd-PCR), allows for rapid and precise pathogen detection, completing the entire assay within 2 hours.

Technical specifications

Key features:

  • Utilizes bacteriophages conjugated to magnetic beads for high-specificity Salmonella capture
  • Differentiates viable bacteria from dead ones, reducing false positives
  • Completes detection process, including bacterial capture, DNA extraction, and dd-PCR, in under 2 hours
  • Validated using Salmonella strains from top foodborne outbreak serotypes

Optimization efforts:

  • Evaluation and optimization of bead concentration, temperature, and incubation time
  • Use of specific lytic phages validated in prior research for effective pathogen targeting
Technology readiness level

This technology is at Technology Readiness Level 3, indicating that it has been demonstrated in a controlled laboratory environment with further optimization and validation planned for diverse food and environmental samples. The next steps include optimization and validation in real-world conditions to ensure reliability and effectiveness.


About University of British Columbia

UBC is a comprehensive public research university with major campuses in Vancouver and the Okanagan, among Canada’s largest and most internationally connected. Industry engages through a co-op talent pipeline and collaborative research spaces that include co-located clinical settings and on‑campus testbeds. A dedicated technology transfer office brokers partnerships, manages IP and licensing, and is complemented by an active venture accelerator and incubator network. Research is supported by competitive funding from Canada’s Tri‑Council agencies (NSERC, CIHR, SSHRC) and infrastructure investments from the Canada Foundation for Innovation, alongside provincial and industry sponsorship.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.